$9.30
-0.31[-3.23%]
At close: May 10
$9.30
0[0.00%]
After Hours: 4:14PM EDT
Adverum Biotechnologies
(NASDAQ:ADVM)Latest News for Adverum Biotechnologies Stock (NASDAQ:ADVM)
Adverum Biotechnologies Stock (NASDAQ: ADVM)
Categories: All
Friday, May 10, 2024
Thursday, May 09, 2024
Tuesday, April 30, 2024
Monday, April 29, 2024
Thursday, April 25, 2024
Tuesday, April 23, 2024
Thursday, March 21, 2024
Wednesday, March 20, 2024
Tuesday, March 19, 2024
Monday, March 18, 2024
Thursday, February 08, 2024
- Why Is Blindness Focused-Adverum Biotechnologies Stock Trading Lower Today?Vandana Singh - Feb 8, 2024, 2:59PM
- Adverum Biotechnologies Announced Preliminary Safety And Efficacy Data From The Ongoing LUNA Phase 2 Trial Of Ixoberogene Soroparvovec In Patients With Wet Age-related Macular DegenerationBenzinga Newsdesk - Feb 8, 2024, 7:15AM
Tuesday, February 06, 2024
Monday, February 05, 2024
- Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Feb 5, 2024, 12:56PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Feb 5, 2024, 12:31PM
- Why Adverum Biotechnologies Stock Is Trading HigherErica Kollmann - Feb 5, 2024, 10:50AM
- Adverum Biotechnologies shares are trading higher after the company announced $127.5 million in private placement financing.Benzinga Newsdesk - Feb 5, 2024, 10:48AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Feb 5, 2024, 8:06AM
- Adverum Biotechnologies Has Agreed To Sell Approximately 106.25M Shares In A Private Placement At $1.20/Share With Gross Proceeds Of Approximately $127.5M; Pro Forma Cash And Investments Expected To Fund Current Operating Plan Into Late 2025Benzinga Newsdesk - Feb 5, 2024, 7:48AM
Thursday, December 07, 2023
Thursday, November 09, 2023
Tuesday, November 07, 2023
Monday, November 06, 2023
Thursday, November 02, 2023
- Adverum Biotechnologies shares are trading higher after Mizuho initiated coverage on the stock with a Buy rating and announced a $2 price target.Benzinga Newsdesk - Nov 2, 2023, 12:57PM
- Mizuho Initiates Coverage On Adverum Biotechnologies with Buy Rating, Announces Price Target of $2Benzinga Newsdesk - Nov 2, 2023, 5:52AM
Tuesday, September 26, 2023
Tuesday, September 05, 2023
Friday, August 11, 2023
Thursday, August 10, 2023
Thursday, June 22, 2023
Wednesday, June 14, 2023
- On June 13, Adverum Biotechnologies Inc Received Written From Nasdaq Stating That Co Has Regained Compliance With Minimum Bid Price RequirementBenzinga Newsdesk - Jun 14, 2023, 4:04PM
- Adverum Biotechnologies Board Member Awarded $79K Worth of Stock OptionsBenzinga Insights - Jun 14, 2023, 11:03AM
- Adverum Biotechnologies Director Awarded $60K Worth of Stock OptionsBenzinga Insights - Jun 14, 2023, 11:02AM
- Adverum Biotechnologies Board Member Awarded $60K Worth of Stock OptionsBenzinga Insights - Jun 14, 2023, 11:01AM
Monday, June 12, 2023
Thursday, May 25, 2023
Thursday, May 18, 2023
- Adverum Biotechnologies Introduces An Intravitreal Gene Therapy Program For Geographic Atrophy And Presents Data On Its Ocular Gene Therapy PlatformHappy Mohamed - May 18, 2023, 9:10AM
- Adverum Biotechnologies Presents Nonclinical Data In Support Of Ixo-vec's Phase 2 Clinical Development At ASGCT 2023 Annual MeetingHappy Mohamed - May 18, 2023, 9:09AM